Combination of Janus kinase inhibitor and biologic for recalcitrant severe atopic dermatitis.
(2025) Journal of the European Academy of Dermatology and Venereology — Vol. 39, n° 1, p. e94-e97 (2025)
Files
AcadDermatolVenereol-2024-DeGreef-CombinationofJanuskinaseinhibitorandbiologicforrecalcitrantsevere.pdf
Open Access - Adobe PDF
- 1.11 MB
Details
- Authors
- Abstract
- Dear Editor, Targeted immune inhibitors (biologics) and Janus kinase (JAK) inhibitors have revolutionized the management of moderate-to-severe atopic dermatitis (AD). However, some patients remain insufficiently controlled with these new systemic immunomodulatory treatments (SITs). Little is known about efficacy and safety of combining the two types of drug classes in patients with recalcitrant or difficult-to-treat AD. [...]
- Affiliations
Citations
De Greef, A., & Baeck, M. (2025). Combination of Janus kinase inhibitor and biologic for recalcitrant severe atopic dermatitis. Journal of the European Academy of Dermatology and Venereology, 39(1), e94-e97. https://doi.org/10.1111/jdv.20132 (Original work published 2025)